引入工程益生菌以改善慢性疾病治疗的肠道微生态:现状和前景
Jianquan Guo1,2, Bangyuan Zhou2, Yali Niu2
1Key Laboratory of Coal Environmental Pathogenicity and Prevention, (Shanxi Medical University), Ministry of Education, Taiyuan, PR China.
Journal of diabetes and metabolic disorders
|November 17, 2023
概括
合成生物学为慢性疾病提供了基于肠道微生态的强大和可控的治疗方法,超越了传统方法. 这种方法对代谢,消化和神经退行性疾病有希望.
科学领域:
- 微生物学和合成生物学
- 胃肠病学和慢性疾病管理
背景情况:
- 肠道微生态失衡是慢性疾病的一个关键因素.
- 传统疗法,如益生菌,益生菌和便微生物群移植,在安全性和控制方面存在局限性.
- 合成生物学为基于肠道微生态的更强大,更可控的治疗方法提供了下一代方法.
研究的目的:
- 审查合成生物学在为慢性疾病开发基于肠道微生态的治疗方法中的应用.
- 突出合成生物学在推进微生态疗法的潜力.
主要方法:
- 从1990年到2023年实验研究和评论的文献搜索.
- 专注于合成生物学在基于肠道微生态的慢性疾病治疗方法中的应用.
主要成果:
- 合成生物学正在应用于治疗代谢性疾病 (糖尿病,肥胖,NAFLD,基尿症).
- 应用范围扩展到消化系统疾病 (IBD,结肠直肠癌) 和神经退行性疾病 (阿尔茨海默氏症,帕金森氏症).
结论:
- 合成生物学为基于肠道微生态的慢性疾病治疗提供了先进的,可控制的解决方案.
- 本综述讨论了机遇和挑战,为合成生物学在微生态疗法中的临床应用铺平了道路.
更多相关视频
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Bacterial Flora of the Large Intestine
473
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
473
Inflammatory Bowel Disease IV: Pharmacological Management
132
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
132
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
337
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
337
Drugs for Treatment of Constipation-Predominant IBS
180
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
180
Biological Methods for Microbial Control
33
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
33


